Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension

Authors: Losartan Trial Investigators; Manolis A.J.; Grossman E.; Jelakovic B.; Jacovides A.; Bernhardi D.C.; Cabrera W.J.; Watanabe L.A.; Barragan J.; Matadamas N.; Mendiola A.; Woo K.S.; Zhu J.R.; Mejia A.D.; Bunt T.; Dumortier T.; Smith R.D.1

Source: Clinical Therapeutics, Volume 22, Number 10, October 2000 , pp. 1186-1203(18)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: angiotensin II antagonist; antihypertensive therapy; losartan; candesartan hydrochlorothiazide

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(00)83062-3

Affiliations: 1: nMerck & Co, Inc, , Whitehouse Station, New Jersey, U.S.A.

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A